Common TitleCOSMOS
Official Title Simeprevir plus Sofosbuvir, with or without Ribavirin, to Treat Chronic Infection with Hepatitis C Virus Genotype 1 in Non-Responders to Pegylated Interferon and Ribavirin and Treatment-Naive Patients: the COSMOS Randomised Study
Phase Phase II
ClinicalTrials.gov NCT01466790
Treatments
Sofosbuvir
, Sofosbuvir
Tradename:SovaldiOther Names:SOFClass:FDA-ApprovedSimeprevir
Simeprevir
Tradename:OlysioOther Names:SMVClass:DiscontinuedFunding
IndustryJanssen